These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 19424002)
1. Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Dominici M; Paolucci P; Conte P; Horwitz EM Transplantation; 2009 May; 87(9 Suppl):S36-42. PubMed ID: 19424002 [TBL] [Abstract][Full Text] [Related]
2. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Arthur A; Zannettino A; Gronthos S J Cell Physiol; 2009 Feb; 218(2):237-45. PubMed ID: 18792913 [TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Sorrentino A; Ferracin M; Castelli G; Biffoni M; Tomaselli G; Baiocchi M; Fatica A; Negrini M; Peschle C; Valtieri M Exp Hematol; 2008 Aug; 36(8):1035-46. PubMed ID: 18504067 [TBL] [Abstract][Full Text] [Related]
4. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Horwitz EM; Le Blanc K; Dominici M; Mueller I; Slaper-Cortenbach I; Marini FC; Deans RJ; Krause DS; Keating A; Cytotherapy; 2005; 7(5):393-5. PubMed ID: 16236628 [TBL] [Abstract][Full Text] [Related]
5. Concise review: multipotent mesenchymal stromal cells in blood. He Q; Wan C; Li G Stem Cells; 2007 Jan; 25(1):69-77. PubMed ID: 16973831 [TBL] [Abstract][Full Text] [Related]
6. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Phinney DG; Prockop DJ Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of mesenchymal stromal cell preparations. Ho AD; Wagner W; Franke W Cytotherapy; 2008; 10(4):320-30. PubMed ID: 18574765 [TBL] [Abstract][Full Text] [Related]
8. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364 [TBL] [Abstract][Full Text] [Related]
9. The role of stromal stem cells in tissue regeneration and wound repair. Stappenbeck TS; Miyoshi H Science; 2009 Jun; 324(5935):1666-9. PubMed ID: 19556498 [TBL] [Abstract][Full Text] [Related]
10. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Samuelsson H; Ringdén O; Lönnies H; Le Blanc K Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151 [TBL] [Abstract][Full Text] [Related]
11. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Schallmoser K; Bartmann C; Rohde E; Reinisch A; Kashofer K; Stadelmeyer E; Drexler C; Lanzer G; Linkesch W; Strunk D Transfusion; 2007 Aug; 47(8):1436-46. PubMed ID: 17655588 [TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Zhou B; Han ZC; Poon MC; Pu W Med Hypotheses; 2007; 68(6):1268-71. PubMed ID: 17197116 [TBL] [Abstract][Full Text] [Related]
13. In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Kaltz N; Funari A; Hippauf S; Delorme B; Noël D; Riminucci M; Jacobs VR; Häupl T; Jorgensen C; Charbord P; Peschel C; Bianco P; Oostendorp RA Stem Cells; 2008 Sep; 26(9):2419-24. PubMed ID: 18617685 [TBL] [Abstract][Full Text] [Related]
15. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Montesinos JJ; Flores-Figueroa E; Castillo-Medina S; Flores-Guzmán P; Hernández-Estévez E; Fajardo-Orduña G; Orozco S; Mayani H Cytotherapy; 2009; 11(2):163-76. PubMed ID: 19152152 [TBL] [Abstract][Full Text] [Related]
16. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Can A; Karahuseyinoglu S Stem Cells; 2007 Nov; 25(11):2886-95. PubMed ID: 17690177 [TBL] [Abstract][Full Text] [Related]
17. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Horn P; Bork S; Diehlmann A; Walenda T; Eckstein V; Ho AD; Wagner W Cytotherapy; 2008; 10(7):676-85. PubMed ID: 18985474 [TBL] [Abstract][Full Text] [Related]
18. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. Abdallah BM; Kassem M J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996 [TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism. Gottschling S; Saffrich R; Seckinger A; Krause U; Horsch K; Miesala K; Ho AD Stem Cells; 2007 Mar; 25(3):798-806. PubMed ID: 17110618 [TBL] [Abstract][Full Text] [Related]
20. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains. Barzilay R; Sadan O; Melamed E; Offen D Cytotherapy; 2009; 11(4):435-42. PubMed ID: 19521891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]